Alessia Burocchi
Nerviano, 20014, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Discovery and optimization of 4-pyrazolyl-2-aminopyrimidine derivatives as potent spleen tyrosine kinase (SYK) inhibitors.
Journal: European journal of medicinal chemistry
Published: February 07, 2024
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis.
Journal: Oncoimmunology
Published: February 05, 2018
Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 19, 2016
Regulated Expression of miR-155 is Required for iNKT Cell Development.
Journal: Frontiers in immunology
Published: December 17, 2014
Mast cells control the expansion and differentiation of IL-10-competent B cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: October 01, 2014
Osteopontin shapes immunosuppression in the metastatic niche.
Journal: Cancer research
Published: July 19, 2014
Convergences and divergences of thymus- and peripherally derived regulatory T cells in cancer.
Journal: Frontiers in immunology
Published: May 23, 2013
Intratumor OX40 stimulation inhibits IRF1 expression and IL-10 production by Treg cells while enhancing CD40L expression by effector memory T cells.
Journal: European journal of immunology
Published: January 10, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026